pharmaceutical investing KemPharm Announces Positive Topline Results from Oral Human Abuse Potential Trial of KP415 Prodrug
pharmaceutical investing KemPharm Announces Top Line Results from KP415.E01 Efficacy and Safety Trial in Children With ADHD
Golconda Gold Announces the Election of Paul Olmsted and James Colter Eadie to the Board of Directors
Standard Uranium Initiates 2026 Drill Program at the Davidson River Uranium Project, Southwest Athabasca Basin
Nuvau Minerals commences PEA study to advance Matagami restart strategy, which includes a fully permitted critical metals mine
